Measuring relative lysosomal volume for monitoring lysosomal storage diseases

Methods in Cell Biology

Volumn 126, Issue , 2015, Pages 331-347

  te Vruchte, Danielle ^a   Wallom, Kerri L ^a   Platt, Frances M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Biomarker; Cellular assay; Flow cytometry; Lysosomal storage disease; Lysosome; LysoTracker; Relative lysosomal volume

Indexed keywords

CD19 ANTIGEN;

ANIMAL; B LYMPHOCYTE; HUMAN; LYSOSOME; LYSOSOME STORAGE DISEASE; METABOLISM; ORGANELLE SIZE; PATHOLOGY;

ANIMALS; ANTIGENS, CD19; B-LYMPHOCYTES; HUMANS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; ORGANELLE SIZE;

EID: 84922912904     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.mcb.2014.10.027     Document Type: Article

References (17)

1. Beutler E. Lysosomal storage diseases: natural history and ethical and economic aspects. Molecular Genetics and Metabolism 2006, 88:208-215.
2. Bright N.A., Gratian M.J., Luzio J.P. Endocytic delivery to lysosomes mediated by concurrent fusion and kissing events in living cells. Current Biology 2005, 15:360-365.
3. Calcraft P.J., Ruas M., Pan Z., Cheng X., Arredouani A., Hao X., et al. NAADP mobilizes calcium from acidic organelles through two-pore channels. Nature 2009, 459:596-600.
4. Churchill G.C., Okada Y., Thomas J.M., Genazzani A.A., Patel S., Galione A. NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs. Cell 2002, 111:703-708.
5. Gadola S.D., Silk J.D., Jeans A., Illarionov P.A., Salio M., Besra G.S., et al. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. Journal of Experimental Medicine 2006, 203:2293-2303.
6. Hemsley K.M., Hopwood J.J. Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders. Journal of Inherited Metabolic Disease 2010, 33:363-371.
7. Lachmann R.H., te Vruchte D., Lloyd-Evans E., Reinkensmeier G., Sillence D.J., Fernandez-Guillen L., et al. Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C. Neurobiology of Disease 2004, 16:654-658.
8. Lloyd-Evans E., Morgan A.J., He X., Smith D.A., Elliot-Smith E., Sillence D.J., et al. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nature Medicine 2008, 14:1247-1255.
9. Luzio J.P., Pryor P.R., Bright N.A. Lysosomes: fusion and function. Nature Reviews Molecular Cell Biology 2007, 8:622-632.
10. Platt F.M. Sphingolipid lysosomal storage disorders. Nature 2014, 510:68-75.
11. Platt F.M., Boland B., van der Spoel A.C. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. Journal of Cell Biology 2012, 199:723-734.
12. Speak A.O., Te Vruchte D., Davis L.C., Morgan A.J., Smith D.A., Yanjanin N.M., et al. Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1. Blood 2014, 123:51-60.
13. te Vruchte D., Speak A.O., Wallom K.L., Al Eisa N., Smith D.A., Hendriksz C.J., et al. Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker. Journal of Clinical Investigation 2014, 124:1320-1328.
14. Vitner E.B., Platt F.M., Futerman A.H. Common and uncommon pathogenic cascades in lysosomal storage diseases. Journal of Biological Chemistry 2010, 285:20423-20427.
15. Winchester B., Vellodi A., Young E. The molecular basis of lysosomal storage diseases and their treatment. Biochemical Society Transactions 2000, 28:150-154.
16. Wraith J.E. Lysosomal disorders. Seminars in Neonatology 2002, 7:75-83.
17. Zoncu R., Bar-Peled L., Efeyan A., Wang S., Sancak Y., Sabatini D.M. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H-ATPase. Science 2011, 334:678-683.